← Back to headlines
H.C. Wainwright Remains Bullish on Eton Pharmaceuticals’ Growth Strategy
H.C. Wainwright has maintained its bullish outlook on Eton Pharmaceuticals' (ETON) growth strategy. The firm expresses continued confidence in the company's plans for expansion and development.
23 May, 12:16 — 23 May, 12:16
Sources
Showing 1 of 1 sources
